FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB:NRGX) (the “Company”), a biotechnology company developing innovative gene therapies for the brain and central nervous system, announced today its
For more information, please visit
http://www.businesswire.com/news/home/20090812005154/en